FIG
AEON.WS

Fortress Investment Group’s AEON Biopharma Inc AEON.WS Stock Holding History

Fortress Investment Group’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-46,138
Closed -$2.1K – 75
2022
Q4 		$2.1K Hold
46,138
– – ﹤0.01% 99
2022
Q3 		$3K Hold
46,138
– – ﹤0.01% 137
2022
Q2 		$7K Hold
46,138
– – ﹤0.01% 147
2022
Q1 		$14K Sell
46,138
-3,861
-8% -$1.59K ﹤0.01% 172
2021
Q4 		$25K Hold
49,999
– – ﹤0.01% 308
2021
Q3 		$29K Hold
49,999
– – ﹤0.01% 292
2021
Q2 		$51K Buy
+49,999
New +$37.9K ﹤0.01% 281

Other funds holding AEON.WS

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Fortress Investment Group's AEON.WS Position: Q1 2023 in Review

Fortress Investment Group sold out of AEON Biopharma Inc (AEON.WS) in Q1 2023, closing a stake of 46,138 shares — an estimated $2.1K sold.

Fortress Investment Group first reported a position in AEON.WS in Q2 2021 and held it in 7 quarters. The position peaked at $51K in Q2 2021. 49 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2023.

  • Fortress Investment Group reported no remaining AEON Biopharma Inc position as of Q1 2023 after selling out during the quarter.
  • Fortress Investment Group sold 46,138 AEON Biopharma Inc shares in Q1 2023, an estimated $2.1K.
  • Fortress Investment Group first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 7 quarters.
  • Fortress Investment Group's AEON Biopharma Inc position peaked at $51K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2023.

Based on Fortress Investment Group's 13F filing for Q1 2023, filed 15 May 2023.